Caitlin John’s Medifast MED Stock Holding History

Caitlin John’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$488	Hold	46	–	–	﹤0.01%	943
2026 Q1	$469	Hold	46	–	–	﹤0.01%	861
2025 Q4	$491	Sell	46 -11	-19%	-$132	﹤0.01%	854
2025 Q3	$783	Buy	+57	New	+$796	﹤0.01%	789
2025 Q1	–	Sell	-57	Closed	-$1.01K	–	529
2024 Q4	$1.01K	Hold	57	–	–	﹤0.01%	728
2024 Q3	$1.12K	Hold	57	–	–	﹤0.01%	723
2024 Q2	$1.25K	Hold	57	–	–	﹤0.01%	701
2024 Q1	$2.19K	Hold	57	–	–	﹤0.01%	669
2023 Q4	$3.85K	Buy	+57	New	+$3.97K	﹤0.01%	596

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Caitlin John's MED Position: Q2 2026 in Review

Caitlin John held its Medifast (MED) position steady in Q2 2026 at 46 shares worth $488. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Caitlin John first reported a position in MED in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.85K in Q4 2023. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Caitlin John held 46 shares of Medifast worth $488 as of Q2 2026.
Caitlin John left its Medifast share count unchanged in Q2 2026.
Medifast made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #943 holding.
Caitlin John first reported a position in Medifast in Q4 2023 and has held it in 9 quarters since.
Caitlin John's Medifast position peaked at $3.85K in Q4 2023.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.